Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches
HC Chen, CW Wang, WH Toh, HE Lee… - Clinical Reviews in …, 2023 - Springer
Bullous pemphigoid is one of the most common autoimmune bullous diseases occurring
primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230 at the dermal …
primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230 at the dermal …
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
L Mateu-Arrom, L Puig - Expert Review of Clinical Pharmacology, 2024 - Taylor & Francis
Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …
Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the “Flip‐Flop” phenomenon)
S Müller, T Welchowski, M Schmid, L Maintz… - Allergy, 2024 - Wiley Online Library
Background Atopic dermatitis (AD) and psoriasis vulgaris (PV) are almost mutually exclusive
diseases with different immune polarizations, mechanisms and therapeutic targets. Switches …
diseases with different immune polarizations, mechanisms and therapeutic targets. Switches …
From molecular insights to clinical perspectives in drug-associated bullous pemphigoid
B de Nicolas-Ruanes, A Ballester-Martinez… - International Journal of …, 2023 - mdpi.com
Bullous pemphigoid (BP), the most common autoimmune blistering disease, is characterized
by the presence of autoantibodies targeting BP180 and BP230 in the basement membrane …
by the presence of autoantibodies targeting BP180 and BP230 in the basement membrane …
State-of-the-art diagnosis of autoimmune blistering diseases
N van Beek, MM Holtsche, I Atefi, H Olbrich… - Frontiers in …, 2024 - frontiersin.org
Autoimmune blistering disorders (AIBDs) are a heterogeneous group of approximately a
dozen entities comprising pemphigus and pemphigoid disorders and dermatitis …
dozen entities comprising pemphigus and pemphigoid disorders and dermatitis …
Concomitant severe psoriasis and bullous pemphigoid induced by COVID-19
F Martora, T Battista, G Fabbrocini… - Tropical Medicine and …, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), first isolated in Wuhan, China, is currently a pandemic. At the …
coronavirus 2 (SARS-CoV-2), first isolated in Wuhan, China, is currently a pandemic. At the …
Causal association between psoriasis vulgaris and bullous pemphigoid: a two-sample bidirectional Mendelian randomization study
A Zhang, Z Yang, T Huang, M Wang - Frontiers in Immunology, 2024 - frontiersin.org
Background The association between psoriasis vulgaris and bullous pemphigoid (BP)
remains largely unknown. Objectives To investigate whether there is a causal effect between …
remains largely unknown. Objectives To investigate whether there is a causal effect between …
Bullous pemphigoid burden of disease, management and unmet therapeutic needs
VP Werth, DF Murrell, P Joly… - Journal of the …, 2024 - Wiley Online Library
Bullous pemphigoid (BP) is an autoimmune blistering disease that can have a profound
negative impact on quality of life. BP most often affects the elderly, a population with a high …
negative impact on quality of life. BP most often affects the elderly, a population with a high …
Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy
K Drenovska, E Valeva, M Shahid, S Vassileva - Frontiers in Medicine, 2023 - frontiersin.org
Autoimmune blistering diseases of the skin have all been reported in patients with psoriasis,
bullous pemphigoid (BP) being the most frequently observed. The pathophysiologic triggers …
bullous pemphigoid (BP) being the most frequently observed. The pathophysiologic triggers …
[HTML][HTML] Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature
AP Lugli, G Caldarola, GM Falco, C Montedoro… - Drugs in …, 2024 - ncbi.nlm.nih.gov
Bullous pemphigoid (BP) is an autoimmune bullous disease, typically affecting the elderly,
characterized by the production of autoantibodies directed against structural components of …
characterized by the production of autoantibodies directed against structural components of …